Provenienza dei contatti di primo grado di Anne-Marie Elsley
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Other | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Anne-Marie Elsley tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer | |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Pharmaceuticals: Generic | Chairman | |
Calcivis Ltd.
 Calcivis Ltd. Medical DistributorsDistribution Services Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom. | Medical Distributors | Chairman | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
| BTG | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member | |
| ELECTRICAL GEODESICS INC | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| University of Lund | College/University | Corporate Officer/Principal | |
| University of Leiden | College/University | Graduate Degree Doctorate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| NOVACYT | Medical Specialties | Director/Board Member | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Director/Board Member | |
BioCity Group Ltd
 BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
BiognoSYS AG
 BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman | |
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Investment Managers | Consultant / Advisor | |
| ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Chori Pars AB | Chief Executive Officer | ||
Royal Society of Edinburgh
 Royal Society of Edinburgh Investment Trusts/Mutual FundsMiscellaneous The Royal Society of Edinburgh provides investment advice. The non-profit company is based in Edinburgh, UK and has subsidiaries in the United Kingdom. | Investment Trusts/Mutual Funds | Director/Board Member | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| University of Rochester Simon Business School | College/University | Masters Business Admin | |
| YOURGENE HEALTH | Medical Specialties | Chairman | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chairman | |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Specialty | Chairman | |
Essential Pharmaceuticals LLC
 Essential Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Intas Pharmaceuticals Ltd., Essential Pharmaceuticals LLC is a company that manufactures and markets pharmaceutical products. The company is based in Durham, NC. The company was founded in 2006. Emma Jane Johnson has been the CEO of the company since 2023. Essential Pharmaceuticals was acquired by Accord Healthcare, Inc. on July 26, 2017. | Pharmaceuticals: Major | Chairman | |
Essential Pharmaceuticals Ltd.
 Essential Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Gyrus Capital SA | Investment Managers | Private Equity Investor | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| Medinvest AB | Private Equity Investor | ||
| F2g Inc. | Director/Board Member | ||
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Pharmaceuticals: Other | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 17 |
| Regno Unito | 15 |
| Svezia | 9 |
| Svizzera | 5 |
| Paesi Bassi | 3 |
Settori
| Health Technology | 35 |
| Finance | 6 |
| Consumer Services | 4 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 94 |
| Independent Dir/Board Member | 29 |
| Director of Finance/CFO | 28 |
| Chairman | 26 |
| Corporate Officer/Principal | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| John Brown | 36 |
| Ed Borkowski | 32 |
| Carl Johan Kördel | 31 |
| Patrick Volkert Vink | 30 |
| Christine Soden | 18 |
| Gary Gemignani | 13 |
| Pieter van der Meer | 12 |
| Scott A. Byrd | 11 |
| Gabriel Fox | 5 |
| Debra M. Hussain | 4 |
| Michael Bolinder | 3 |
| Alessandro della Chà | 1 |
- Borsa valori
- Insiders
- Anne-Marie Elsley
- Connessioni Società
